*By Carlo Versano*
Paul Allen, who co-founded Microsoft with Bill Gates and went on to become one of the country's most prolific philanthropists and technologists, died Monday at 65.
His company Vulcan released a [statement](http://www.vulcan.com/News/Articles/2018/Statement-on-Paul-G-Allen) saying the cause was non-Hodgkin's lymphoma, which Allen had battled on and off for years.
Allen and Gates famously started Microsoft ($MSFT) in 1975 after dropping out of college and partnering to write computer code for early PCs. The break that would elevate their tiny company ー whose name was a *portmanteau* of "microcomputer software" that Allen came up with ー and make both men fabulously wealthy came when IBM ($IBM) chose it as the software supplier for that company's first personal computer.
Allen left Microsoft in the early 80s but remained on the board until 2000. Current CEO Satya Nadella said in a statement: "As co-founder of Microsoft, in his own quiet and persistent way, he created magical products, experiences and institutions, and in doing so, he changed the world."
As Allen became one of the world's richest people ー Forbes [estimates](https://www.forbes.com/profile/paul-allen/#7bd56f414417) his estate to be worth at least $20 billion ー he became known for his charitable largesse, nowhere more so than in Seattle, where he lived. He also bought sports teams ー he was owner of the NFL's Seahawks and the NBA's Portland Trail Blazers ー turning them into billion-dollar franchises, opened cultural institutions, donated to local STEM non-profits, and re-developed a Seattle neighborhood that is now home to a booming science and tech industry, including the headquarters of Amazon ($AMZN). He was regularly [listed](https://www.forbes.com/sites/jenniferwang/2018/10/15/the-greatest-givers-meet-americas-top-philanthropists/#42fc98bd1af1) among America's most generous givers.
Allen is survived by his sister Jody, who [said](http://www.vulcan.com/News/Articles/2018/Statement-on-Paul-G-Allen): " While most knew Paul Allen as a technologist and philanthropist, for us he was a much loved brother and uncle, and an exceptional friend."
Catching you up on what you need to know on April 18, 2022, with Russian missile attacks on the Ukrainian city of Lviv killing seven, mass shootings in South Carolina and Pittsburgh, Lucky Charms cereal under official investigation by the FDA, and more.
Lisa Whalen, Automotive and Mobility Analyst at Morning Consult, joined Cheddar News' Closing Bell to break down the famed auto show's emphasis on electric vehicles this year, reflecting a shift toward electrification in the automotive industry.
Peggy Whitson, Director of Human Space Flight, Axiom Space, joins Cheddar Innovates to discuss Axiom's involvement in the first fully-private mission to the ISS, and her experience spending 665 days in space.
On this episode of Cheddar Innovates, Peggy Whitson, Director of Human Space Flight, Axiom Space, breaks down Axiom's involvement in the first fully-private mission to the ISS, and her experience spending 665 days in space; William Li and Danielle Chang, co-founders of The Hao Life, discuss how they're shaking up the $71 billion supplement industry by putting a modern spin on traditional natural Chinese remedies; Cheddar gets a look at Curiosity Stream's 'Sagrada Familia: Gaudi's Challenge.'
On this episode of Cheddar Innovates: President of The Pillow Bar breaks down how everyone can benefit from a pillow customized to their unique way of sleeping; CEO of H2Pro explains how to bring environmentally friendly hydrogen to scale; Cheddar gets a look at Curiosity Stream's 'Suppressed Science.'
On this episode of Cheddar Innovates: Gardenuity CEO breaks down how gardening can improve your wellbeing; Augmedix CEO discusses how this technology is helping doctors fight burnout; Cheddar gets a look at Curiosity Stream's 'Suppressed Science.'
On this episode of Cheddar Innovates: Atom Limbs CEO breaks down how the Atom Touch prosthetic is different from other prosthetics on the market; CEO & Chief Scientific Officer of MyMD explains how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases; A look at Curiosity Stream's 'The Future of Warfare.'
